Nevena Skroza

Pubblicazioni

Titolo Pubblicato in Anno
The dermatological effects and occupational impacts of personal protective equipment on a large sample of healthcare workers during the COVID-19 pandemic FRONTIERS IN PUBLIC HEALTH 2022
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema DERMATOLOGY REPORTS 2022
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study ARCHIVES OF DERMATOLOGICAL RESEARCH 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year EXPERT OPINION ON BIOLOGICAL THERAPY 2022
Hidradenitis suppurativa in a large cohort of italian patients. Evaluation of the burden of disease DERMATOLOGY 2022
PSSD and biologic therapy: real-life data in 417 patients with moderate to severe psoriasis REVIEWS ON RECENT CLINICAL TRIALS 2022
Safety and impact of anti-COVID-19 vaccines in psoriatic patients treated with biologics. A real life experience JOURNAL OF CLINICAL MEDICINE 2021
How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception. Study on 600 patients on biologic therapy JOURNAL OF INFECTION AND PUBLIC HEALTH 2021
Long-term maintained response to selective internal radiation therapy in an oligometastatic uveal melanoma patient treated with concomitant Anti-PD-1 therapy LIFE 2021
An open-label study comparing oral zinc to lymecycline in the treatment of acne vulgaris THE JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY 2021
Metastatic penile squamous cell carcinoma successfully treated with cemiplimab in an HIV patient DERMATOLOGIC THERAPY 2021
Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis DERMATOLOGIC THERAPY 2021
A curious case of opticneuritis in hidradenitis suppurativa patient, successfullytreated with adalimumab EXPERIMENTAL DERMATOLOGY 2021
A novel azelaic acid formulation for the topical treatment of inflammatory rosacea. A multicentre, prospective clinical trial JOURNAL OF COSMETIC DERMATOLOGY 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa. Results of a prospective European cohort study JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2021
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa. Results from an Italian multicentric retrospective study in a real-life setting JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2021
Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY 2021
Aesthetic treatments in cancer patients CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY 2021
Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data FRONTIERS IN PHARMACOLOGY 2021
Erythrodermic psoriasis successfully treated with Anti IL-17. A case series ACTA DERMATOVENEROLOGICA CROATICA 2021

ERC

  • LS7
  • LS7_4
  • LS7_9

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Malattie immunomediate  croniche cutanee (psoriasi, acne, idrosadenite suppurativa, dermatite atopica, orticaria cronica), Oncologia dermatologica (Cheratosi attinica, Non melanoma skin cancer, Melanoma)

Medicina rigenerativa

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma